Patients and caregivers know better than anyone what it is like to live with a serious disease. We listen. And we learn from people’s experiences. We work together to create medicines that address the needs of people living with disease and achieve the results that matter to them.

The Novartis commitment to patients and caregivers

We recognize the importance of patients and caregivers understanding what they can expect from Novartis.

 

Our work with patients and caregivers is built on four commitments

 

1. Respecting and understanding the patient community perspective

2. Expanding access to our medicines

3. Conducting responsible clinical trials

4. Recognizing the importance of transparency and reporting

Read more about our commitment to patients and caregivers here.

40+

Patient organizations represented

78k+

Novartis associates own it as an aspiration*

doctor and nurse

Disclosure of patient organization funding

Novartis annually discloses monetary and non-monetary support to patient organizations around the globe by June 30.

 

Our commitment – reporting 2023 progress

 

90%

Medicines in early research with patient input

People living with disease provided insights before first-in-human trials (healthy volunteers).

6 118

Patients reached through managed access programs

95% requests approved for 50 compounds in 72 countries - providing access to locally unlicensed Novartis medicines.

32

Clinical development programs

consulted people living with disease on the design and/or conduct of clinical trials.

197

Clinical trials

included patient reported outcomes (PRO) conducted in 79 countries.

266

Simplified summaries

from Phase I-IV clinical trials sent to investigators to share with 40 000 trial participants and posted on ishraqtimes.com/clinicaltrials.

33.2 million

Patients

reached through access programs.

 


Collaborations with patient organizations

Japanese doctor and patients discussing illness

Listening to the CML patient community

Improving the patient experience and removing potential barriers to clinical trial participation

Doctor with senior woman in an office

Patient organizations and Novartis

Working together with patient organizations and healthcare organizations helps us create better medicines. This collaboration is based on values of mutual respect, trust and transparency.


men handshake_0

External funding

Novartis may provide funding to legitimate organizations to support its mission to discover new ways to improve and extend people's lives, advance scientific and medical knowledge, and supporting the communities where Novartis associates live and work.

mother daughter hug

Patient perspectives

Patients and caregivers know better than anyone what it is like to live with a serious disease. Visit our YouTube channel to watch our patient stories to learn more about insights from the patient community.

For questions about Novartis, medical inquiries about our products and/or information about services, we recommend you contact the Novartis office in your country. If you’re seeking a global list of products, visit our Global Product Portfolio.

*Based on 2022 data except for employees which has been restated to exclude Sandoz